SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,601 | -56.2% | 175 | 0.0% | 0.00% | – |
| Q2 2023 | $8,228 | +12.1% | 175 | 0.0% | 0.00% | – |
| Q1 2023 | $7,343 | +104800.0% | 175 | -5.4% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 185 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +40.0% | 185 | +5.7% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 175 | -9.8% | 0.00% | – |
| Q1 2022 | $6,000 | -14.3% | 194 | +10.9% | 0.00% | – |
| Q4 2021 | $7,000 | 0.0% | 175 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | -30.0% | 175 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | -23.1% | 175 | 0.0% | 0.00% | – |
| Q1 2021 | $13,000 | -13.3% | 175 | 0.0% | 0.00% | – |
| Q4 2020 | $15,000 | +36.4% | 175 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | +57.1% | 175 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 175 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -66.7% | 175 | -14.6% | 0.00% | -100.0% |
| Q4 2019 | $15,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |